The Extracellular, Transmembrane and Intracellular Domains of MPZ for Drug Development

Target Name: MPZ

NCBI ID: G4359

Content of Review Report on MPZ Target / Biomarker

MPZ

The Extracellular, Transmembrane and Intracellular Domains of MPZ for Drug Development

MPZ (Mesothelin-Positive Zinc Toxin) is a drug target and a biomarker that has been identified for various diseases, including cancer, heart disease, and neurodegenerative disorders. MPZ is a transmembrane protein that is expressed in various tissues, including the placenta, brain, and cancer cells. It is composed of four structural domains, including an extracellular domain, a transmembrane domain, an intracellular domain, and a C-terminal domain that contains a zinc ion.

The Extracellular Domain

The extracellular domain of MPZ is the largest and most well-studied domain. It is involved in the formation ofMPZ monomers and in its ability to interact with various cell surface receptors. The extracellular domain contains several key features that are important for its function. One of these features is a long N-terminus that is involved in the formation ofMPZ monomers. The N-terminus of MPZ contains a critical region that is involved in the formation of the monomeric state and in its ability to interact with various cell surface receptors.

The Transmembrane Domain

The transmembrane domain of MPZ is a critical region that spans the entire length of the membrane. It is involved in the regulation of the cell's cytoskeleton and in the formation of the monomeric state. The transmembrane domain of MPZ contains several key features that are important for its function. One of these features is a transmembrane region that is involved in the formation of the monomeric state. The transmembrane region of MPZ contains a critical region that is involved in the formation of the monomeric state and in its ability to interact with various cell surface receptors.

The Intracellular Domain

The intracellular domain of MPZ is the region that lies inside the membrane. It is involved in the regulation of the cell's cytoskeleton and in the formation of the monomeric state. The intracellular domain of MPZ contains several key features that are important for its function. One of these features is a cytoplasmic region that is involved in the regulation of the cell's cytoskeleton. The cytoplasmic region of MPZ contains a critical region that is involved in the regulation of the cell's cytoskeleton and in the formation of the monomeric state.

The C-Terminal Domain

The C-terminal domain of MPZ is the region that lies at the cytoplasmic side of the membrane. It is involved in the regulation of the cell's cytoskeleton and in the formation of the monomeric state. The C-terminal domain of MPZ contains several key features that are important for its function. One of these features is a zinc ion-binding site that is involved in the regulation of the cell's cytoskeleton and in the formation of the monomeric state.

The Drug Target Status

MPZ is a drug target and a biomarker that has been identified for various diseases, including cancer, heart disease, and neurodegenerative disorders. The drug target status of MPZ makes it an attractive target for drug development. The zinc ion-binding site in the C-terminal domain of MPZ is a potential drug target. Zinc ions have been shown to play a critical role in various cellular processes, including cell signaling, DNA replication, and inflammation. Therefore, inhibition of the zinc ion-binding site in MPZ could potentially lead to the inhibition of various cellular processes that are critical for the disease.

The Potential Therapeutic Benefits

The drug target status of MPZ makes it an attractive target for drug development. The zinc ion-binding site in the C-terminal domain of MPZ is a potential drug target. If inhibition of

Protein Name: Myelin Protein Zero

Functions: Is an adhesion molecule necessary for normal myelination in the peripheral nervous system. It mediates adhesion between adjacent myelin wraps and ultimately drives myelin compaction

The "MPZ Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPZ comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets